Regemat 3D
About:
REGEMAT3D, a biotech company pioneer in the use of 3D printing for regenerative therapies.
Website: http://www.regemat3d.com/
Twitter/X: regemat3D
Top Investors: Crowdcube
Description:
REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in a new and promising area called bioprinting, that uses 3D printing technologies for regenerative therapies. REGEMAT3D is a bioprinting modular system that integrates the latest advances in 3D printing and regenerative therapies to offer adapted solutions to fulfil research's needs. A tested and validated systems, it is adaptable to different types of tissues, to research the biggest unsolved biotechnology problems and to battle different kinds of pathologies, such as; Cardiovascular Disease (CVD), Peripheral Vascular Disease (PVD), Non-healing wounds, Spinal cord injury, Alzheimer´s Disease (AD), Parkinson´s Disease (PD), Musculoskeletal Disorders (MSDs), Autoimmune Disorders, Stroke, Diabetes, and Ocular Disease.
$1.1M
Less than $1M
Armilla, Andalucia, Spain
2015-01-01
info(AT)regemat3d.com
José Manuel Baena
11-50
2022-03-11
Private
© 2025 bioDAO.ai